Compare · BEN vs HQL
BEN vs HQL
Side-by-side comparison of Franklin Resources Inc. (BEN) and abrdn Life Sciences Investors Shares of Beneficial Interest (HQL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BEN and HQL operate in Investment Managers (Finance), so they compete in similar markets.
- BEN is the larger of the two at $17.80B, about 32.0x HQL ($556.5M).
- BEN has been more active in the news (16 items in the past 4 weeks vs 2 for HQL).
- BEN has more recent analyst coverage (24 ratings vs 0 for HQL).
Franklin Resources Inc.
Franklin Resources, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships. It launches equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. The firm invests in the public equity, fixed income, and alternative markets. Franklin Resources, Inc. was founded in 1947 and is based in San Mateo, California with an additional office in Hyderabad, India.
abrdn Life Sciences Investors Shares of Beneficial Interest
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Latest BEN
- Franklin Templeton, Inc. Announces Quarterly Dividend
- Franklin Templeton Canada Announces ETF Cash Distributions
- Franklin Templeton Announces Closing of Inaugural US$1.5 Billion Collateralized Fund Obligation
- SEC Form N-PX filed by Franklin Resources Inc.
- Franklin BSP Capital Corporation Announces Third Quarter 2026 Dividend
- SEC Form 13F-HR filed by Franklin Resources Inc.
- Franklin Resources Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events
- SEC Form 424B5 filed by Franklin Resources Inc.
- Franklin Templeton Canada Announces Fee Waivers Will Continue for Low Volatility High Dividend Index ETFs
- Franklin Templeton Canada Enhances Quotential Portfolios With New Private Market Investment Capabilities
Latest HQL
- SEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Director Mahai Chris Lavictoire bought $10,498 worth of shares (527 units at $19.92) (SEC Form 4)
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form 3 filed by new insider Mahai Chris Lavictoire
- SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts